140 related articles for article (PubMed ID: 23927625)
1. Phenotypic screening as a strategic component of drug discovery programs targeting novel antiparasitic and antimycobacterial agents: an editorial.
Butera JA
J Med Chem; 2013 Oct; 56(20):7715-8. PubMed ID: 23927625
[TBL] [Abstract][Full Text] [Related]
2. Fragment-based screening in tandem with phenotypic screening provides novel antiparasitic hits.
Blaazer AR; Orrling KM; Shanmugham A; Jansen C; Maes L; Edink E; Sterk GJ; Siderius M; England P; Bailey D; de Esch IJ; Leurs R
J Biomol Screen; 2015 Jan; 20(1):131-40. PubMed ID: 25231971
[TBL] [Abstract][Full Text] [Related]
3. Approaches to protozoan drug discovery: phenotypic screening.
Sykes ML; Avery VM
J Med Chem; 2013 Oct; 56(20):7727-40. PubMed ID: 23927763
[TBL] [Abstract][Full Text] [Related]
4. Development of Mycobacterium tuberculosis whole cell screening hits as potential antituberculosis agents.
Cooper CB
J Med Chem; 2013 Oct; 56(20):7755-60. PubMed ID: 23927683
[TBL] [Abstract][Full Text] [Related]
5. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
6. Cell-based medicinal chemistry optimization of high throughput screening hits for orally active antimalarials. Part 2: hits from SoftFocus kinase and other libraries.
Younis Y; Street LJ; Waterson D; Witty MJ; Chibale K
J Med Chem; 2013 Oct; 56(20):7750-4. PubMed ID: 23927599
[TBL] [Abstract][Full Text] [Related]
7. Cell-based medicinal chemistry optimization of high-throughput screening (HTS) hits for orally active antimalarials. Part 1: challenges in potency and absorption, distribution, metabolism, excretion/pharmacokinetics (ADME/PK).
Chatterjee AK
J Med Chem; 2013 Oct; 56(20):7741-9. PubMed ID: 23927720
[TBL] [Abstract][Full Text] [Related]
8. Parasitology. Drugs to combat tropical protozoan parasites.
Gelb MH; Hol WG
Science; 2002 Jul; 297(5580):343-4. PubMed ID: 12130767
[No Abstract] [Full Text] [Related]
9. Computational Methods to Discover Compounds for the Treatment of Chagas Disease.
Cortés-Ruiz EM; Palomino-Hernández O; Rodríguez-Hernández KD; Espinoza B; Medina-Franco JL
Adv Protein Chem Struct Biol; 2018; 113():119-142. PubMed ID: 30149904
[TBL] [Abstract][Full Text] [Related]
10. Drug discovery and the use of computational approaches for infectious diseases.
Marhöfer RJ; Oellien F; Selzer PM
Future Med Chem; 2011 Jun; 3(8):1011-25. PubMed ID: 21707402
[TBL] [Abstract][Full Text] [Related]
11. Next-generation antimicrobials: from chemical biology to first-in-class drugs.
Ang ML; Murima P; Pethe K
Arch Pharm Res; 2015 Sep; 38(9):1702-17. PubMed ID: 26259630
[TBL] [Abstract][Full Text] [Related]
12. Infectious diseases. Tackling neglected diseases could offer more bang for the buck.
Vogel G
Science; 2006 Feb; 311(5761):592-3. PubMed ID: 16456044
[No Abstract] [Full Text] [Related]
13. Mass drug administration and integrated control for the world's high-prevalence neglected tropical diseases.
Hotez PJ
Clin Pharmacol Ther; 2009 Jun; 85(6):659-64. PubMed ID: 19322166
[No Abstract] [Full Text] [Related]
14. Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches.
Urbina JA
Acta Trop; 2010; 115(1-2):55-68. PubMed ID: 19900395
[TBL] [Abstract][Full Text] [Related]
15. Antiparasitic agents: new drugs on the horizon.
Mäser P; Wittlin S; Rottmann M; Wenzler T; Kaiser M; Brun R
Curr Opin Pharmacol; 2012 Oct; 12(5):562-6. PubMed ID: 22652215
[TBL] [Abstract][Full Text] [Related]
16. Phosphonium lipocations as antiparasitic agents.
Long TE; Lu X; Galizzi M; Docampo R; Gut J; Rosenthal PJ
Bioorg Med Chem Lett; 2012 Apr; 22(8):2976-9. PubMed ID: 22414614
[TBL] [Abstract][Full Text] [Related]
17. Neglected tropical diseases: multi-target-directed ligands in the search for novel lead candidates against Trypanosoma and Leishmania.
Cavalli A; Bolognesi ML
J Med Chem; 2009 Dec; 52(23):7339-59. PubMed ID: 19606868
[No Abstract] [Full Text] [Related]
18. In vitro and in silico studies of polycondensed diazine systems as anti-parasitic agents.
Almerico AM; Tutone M; Guarcello A; Lauria A
Bioorg Med Chem Lett; 2012 Jan; 22(2):1000-4. PubMed ID: 22197138
[TBL] [Abstract][Full Text] [Related]
19. Re-starting malaria research at the Novartis Institute for Tropical Diseases (NITD).
Palmer H; Diagana T
Biotechnol J; 2007 Nov; 2(11):1337-8. PubMed ID: 17939125
[No Abstract] [Full Text] [Related]
20. Synthesis, in vitro antitrypanosomal and antibacterial activity of phenoxy, phenylthio or benzyloxy substituted quinolones.
Ma X; Zhou W; Brun R
Bioorg Med Chem Lett; 2009 Feb; 19(3):986-9. PubMed ID: 19095449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
